Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-068116
Filing Date
2022-06-03
Accepted
2022-06-03 16:31:58
Documents
8
Effectiveness Date
2022-06-03

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2217601d1_s8.htm S-8 61171
2 EXHIBIT 4.3 tm2217601d1_ex4-3.htm EX-4.3 81080
3 EXHIBIT 4.4 tm2217601d1_ex4-4.htm EX-4.4 10782
4 EXHIBIT 5.1 tm2217601d1_ex5-1.htm EX-5.1 11761
5 EXHIBIT 23.2 tm2217601d1_ex23-2.htm EX-23.2 2070
6 EX-FILING FEES tm2217601d1_ex-fillingfees.htm EX-FILING FEES 18550
7 GRAPHIC tm2217601d1_ex5-1img001.jpg GRAPHIC 2586
8 GRAPHIC tm2217601d1_ex5-1img002.jpg GRAPHIC 2530
  Complete submission text file 0001104659-22-068116.txt   193752
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265411 | Film No.: 22995012
SIC: 2834 Pharmaceutical Preparations